C. Ormazábal

663 total citations
12 papers, 498 citations indexed

About

C. Ormazábal is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, C. Ormazábal has authored 12 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Genetics. Recurrent topics in C. Ormazábal's work include Bone health and treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). C. Ormazábal is often cited by papers focused on Bone health and treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers) and Sarcoma Diagnosis and Treatment (2 papers). C. Ormazábal collaborates with scholars based in Spain, United Kingdom and Belgium. C. Ormazábal's co-authors include Fernando Lecanda, Carolina Zandueta, Karmele Valencia, Susana Martínez-Canarias, Iker Antón, Diego Luis-Ravelo, Javier De Las Rivas, Eva Bandrés, Jackeline Agorreta and Luis M. Montuenga and has published in prestigious journals such as PLoS ONE, American Journal of Respiratory and Critical Care Medicine and Oncogene.

In The Last Decade

C. Ormazábal

12 papers receiving 492 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Ormazábal Spain 9 283 204 159 85 72 12 498
Susana Martínez-Canarias Spain 9 280 1.0× 206 1.0× 173 1.1× 84 1.0× 71 1.0× 10 476
Iker Antón Spain 9 305 1.1× 214 1.0× 225 1.4× 93 1.1× 76 1.1× 15 538
Giovanni Roveroni Italy 11 173 0.6× 195 1.0× 197 1.2× 67 0.8× 50 0.7× 18 523
Nobuhiko Moniwa Japan 9 201 0.7× 305 1.5× 164 1.0× 32 0.4× 93 1.3× 15 685
Heath B. Acuff United States 6 243 0.9× 259 1.3× 359 2.3× 69 0.8× 99 1.4× 6 576
M. Pucci Italy 8 161 0.6× 252 1.2× 106 0.7× 32 0.4× 81 1.1× 16 394
Xiaokai Yan China 10 496 1.8× 373 1.8× 74 0.5× 63 0.7× 46 0.6× 16 739
Paul Perrotte Canada 7 284 1.0× 179 0.9× 216 1.4× 70 0.8× 42 0.6× 12 552
Shunichi Ishigami Japan 6 105 0.4× 83 0.4× 165 1.0× 41 0.5× 36 0.5× 25 343
M. Toi Japan 5 128 0.5× 69 0.3× 110 0.7× 57 0.7× 34 0.5× 8 344

Countries citing papers authored by C. Ormazábal

Since Specialization
Citations

This map shows the geographic impact of C. Ormazábal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Ormazábal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Ormazábal more than expected).

Fields of papers citing papers by C. Ormazábal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Ormazábal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Ormazábal. The network helps show where C. Ormazábal may publish in the future.

Co-authorship network of co-authors of C. Ormazábal

This figure shows the co-authorship network connecting the top 25 collaborators of C. Ormazábal. A scholar is included among the top collaborators of C. Ormazábal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Ormazábal. C. Ormazábal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Martín-Fernández, Marta, Karmele Valencia, Carolina Zandueta, et al.. (2017). The Usefulness of Bone Biomarkers for Monitoring Treatment Disease: A Comparative Study in Osteolytic and Osteosclerotic Bone Metastasis Models. Translational Oncology. 10(2). 255–261. 8 indexed citations
2.
Zandueta, Carolina, C. Ormazábal, Naiara Perurena, et al.. (2016). Matrix‐Gla protein promotes osteosarcoma lung metastasis and associates with poor prognosis. The Journal of Pathology. 239(4). 438–449. 42 indexed citations
3.
Valencia, Karmele, Diego Luis-Ravelo, Nicolas Bovy, et al.. (2014). miRNA cargo within exosome‐like vesicle transfer influences metastatic bone colonization. Molecular Oncology. 8(3). 689–703. 143 indexed citations
4.
Luis-Ravelo, Diego, Iker Antón, Carolina Zandueta, et al.. (2013). A gene signature of bone metastatic colonization sensitizes for tumor-induced osteolysis and predicts survival in lung cancer. Oncogene. 33(43). 5090–5099. 35 indexed citations
5.
Luis-Ravelo, Diego, Iker Antón, Carolina Zandueta, et al.. (2013). Efectos divergentes de la inhibición de TGF-β en metástasis óseas de cáncer de mama y pulmón. 5(2). 79–84. 1 indexed citations
6.
Valencia, Karmele, C. Ormazábal, Carolina Zandueta, et al.. (2012). Inhibition of Collagen Receptor Discoidin Domain Receptor-1 (DDR1) Reduces Cell Survival, Homing, and Colonization in Lung Cancer Bone Metastasis. Clinical Cancer Research. 18(4). 969–980. 116 indexed citations
7.
Antón, Iker, Diego Luis-Ravelo, Carolina Zandueta, et al.. (2012). Receptor of Activated Protein C Promotes Metastasis and Correlates with Clinical Outcome in Lung Adenocarcinoma. American Journal of Respiratory and Critical Care Medicine. 186(1). 96–105. 45 indexed citations
8.
Valencia, Karmele, Marta Martín-Fernández, Carolina Zandueta, et al.. (2012). miR-326 associates with biochemical markers of bone turnover in lung cancer bone metastasis. Bone. 52(1). 532–539. 42 indexed citations
9.
Cuesta‐Domínguez, Álvaro, C. Ormazábal, Marta Galán-Díez, et al.. (2012). Transforming and Tumorigenic Activity of JAK2 by Fusion to BCR: Molecular Mechanisms of Action of a Novel BCR-JAK2 Tyrosine-Kinase. PLoS ONE. 7(2). e32451–e32451. 26 indexed citations
10.
Aranaz, Paula, Itziar Miguéliz, C. Ormazábal, et al.. (2012). CBL mutations in myeloproliferative neoplasms are also found in the gene's proline-rich domain and in patients with the V617FJAK2. Haematologica. 97(8). 1234–1241. 15 indexed citations
11.
Folio, Cecilia, Marta Zalacaín, Carolina Zandueta, et al.. (2012). Cortactin (CTTN) overexpression in osteosarcoma correlates with advanced stage and reduced survival. Cancer Biomarkers. 10(1). 35–41. 18 indexed citations
12.
Aranaz, Paula, C. Ormazábal, Marı́a José Calasanz, et al.. (2010). A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes. Cancer Genetics and Cytogenetics. 199(1). 1–8. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Susana Martínez-Canarias Breakdown of academic impact, for papers by Iker Antón Breakdown of academic impact, for papers by Giovanni Roveroni Breakdown of academic impact, for papers by Nobuhiko Moniwa Breakdown of academic impact, for papers by Heath B. Acuff Breakdown of academic impact, for papers by M. Pucci Breakdown of academic impact, for papers by Xiaokai Yan Breakdown of academic impact, for papers by Paul Perrotte Breakdown of academic impact, for papers by Shunichi Ishigami Breakdown of academic impact, for papers by M. Toi
Rankless by CCL
2026